Biomedical Engineering Reference
In-Depth Information
[41]
Rahfoth, B. Weisser, J. Sternkopf, F. Aigner, T. von der Mark, K. & Brauer, R. (1998).
Transplantation of allograft chondrocytes embedded in agarose gel into cartilage
defects of rabbits. Osteoarthr. Cartilage , 6 , 50-65.
[42]
Dimicco, M.A. Kisiday, J.D. Gong, H. & Grodzinsky, A.J. (2007). Structure of
pericellular matrix around agarose-embedded chondrocytes. Osteoarthr. Cartilage , 15 ,
1207-1216.
[43]
Alaminos, M. Del Carmen Sanchez Quevedo, M. Munoz Avila, J.I. Serrano, D.
Medialdea, S. Carreras, I. & Campos, A. (2006). Construction of a complete rabbit
cornea substitute using a fibrin-agarose scaffold. Invest. Ophthalmol. Vis. Sci. , 47 ,
3311-3317.
[44]
Rotter, N. Aigner, J. Naumann, A. Hammer, C. & Sittinger, M. (1999). Behavior of
tissue-engineered human cartilage after transplantation into nude mice. J. Mater. Sci.
Mater. Med. , 10 , 689-693.
[45]
Tashiro, H. Iwata, H. Warnock, G.L. Ikada, Y. & Tsuji, T. (1998). Viability studies of
agarose microencapsulation islets of langerhans from dogs. Transplant. Proc. , 30 , 490.
[46]
Tun, T. Inoue, K. Hayashi, H. Aung, T. Gu, Y.-J. Doi, R. Kaji, H. Echigo, Y. Wang,
W.-J. Setoyama, H. Imamura, M. Maetani, S. Norikawa, N. Iwata, H. & Ikada, Y.
(1996). A newly developed three-layer agarose microcapsule for a promising biohybrid
artificial pancreas: Rat to mouse xenotransplantation. Cell Transplant. , 5 , S59-S63.
[47]
Iwata, H. Murakami, Y. & Ikada, Y. (1999). Control of complement activities for
immunoisolation. Ann. N. Y. Acad. Sci. , 875 , 7-23.
[48]
Sakai, S. Kawabata, K. Tanaka, S. Harimoto, N. Hashimoto, I. Mu, C. Salmons, B.
Ijima, H. & Kawakami, K. (2005). Subsieve-size agarose capsules enclosing
ifosfamide-activating cells: a strategy toward chemotherapeutic targeting to tumors.
Mol. Cancer Ther. , 4 , 1786-1790.
[49]
Dirven, H.A. Megens, L. Oudshoorn, M.J. Dingemanse, M.A. van Ommen, B. & van
Bladeren, P.J. (1995). Glutathione conjugation of the cytostatic drug ifosfamide and
the role of human glutathione S-transferases. Chem. Res. Toxicol. , 8 , 979-986.
[50]
Kurowski, V. & Wagner, T. (1993). Comparative pharmacokinetics of ifosfamide, 4-
hydroxyifosfamide, chloroacetaldehyde, and 2- and 3-dechloroethylifosfamide in
patients on fractionated intravenous ifosfamide therapy. Cancer Chemother.
Pharmacol. , 33 , 36-42.
[51]
Lohr, M. Hoffmeyer, A. Kroger, J.C. Freund, M. Hain, J. Holle, A. Karle, P. Knofel,
W.T. Liebe, S. Muller, P. Nizze, H. Renner, M. Saller, R.M. Wagner, T. Hauenstein,
K. Gunzburg, W.H. & Salmons, B. (2001). Microencapsulated cell-mediated treatment
of inoperable pancreatic carcinoma. Lancet , 357 , 1591-1592.
[52]
Lohr, M. Muller, P. Karle, P. Stange, J. Mitzner, S. Jesnowski, R. Nizze, H. Nebe, B.
Liebe, S. Salmons, B. & Gunzburg, W.H. (1998). Targeted chemotherapy by
intratumour injection of encapsulated cells engineered to produce CYP2B1, an
ifosfamide activating cytochrome P450. Gene Ther. , 5 , 1070-1078.
[53]
Lohr, M. Kroger, J.C. Hoffmeyer, A. Freund, M. Hain, J. Holle, A. Knofel, W.T.
Liebe, S. Nizze, H. Renner, M. Saller, R. Karle, P. Muller, P. Wagner, T. Hauenstein,
K. Salmons, B. & Gunzburg, W.H. (2003). Safety, feasibility and clinical benefit of
localized chemotherapy using microencapsulated cells for inoperable pancreatic
carcinoma in a phase I/II trial. Cancer Ther. , 1 , 121-131.
Search WWH ::




Custom Search